Anondita Medicare Key Ratios
NSE: ANONDITA
₹1,144.95
As on 08-Sep-2026 09:34IST
Market cap
₹2,186 Cr
Revenue (TTM)
₹77 Cr
P/E Ratio
65.4
P/B Ratio
50.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | 4,46,847.37 | -- | -- |
| Net Profit | -- | -- | 2,84,305.26 | -- | -- |
| EPS | -- | -- | 3,307.30 | -- | -- |
| Book Value | -- | -- | 243.91 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 32.15 | -- | -- |
| Net Margin
| -- | -- | 21.28 | -- | -- |
| Return on equity
| -- | -- | 43.35 | -- | -- |
| Return on Capital
| -- | -- | 38.15 | -- | -- |
| Return on Assets
| -- | -- | 20.97 | -- | -- |
| Debt to Equity (x)
| -- | -- | 0.72 | -- | -- |
Profitability
ROCE
38.15
Higher than Peers by 25.96
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
38.15
|
--
|
--
|
--
|
--
|
|
Peer Median
|
12.19
|
11.06
|
9.85
|
8.65
|
--
|
ROE
43.35
Higher than Peers by 34.09
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
43.35
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9.26
|
7.17
|
7.54
|
3.52
|
--
|
ROA
20.97
Higher than Peers by 13.33
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
20.97
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.65
|
3.78
|
3.99
|
2.87
|
--
|
EBIT Margin
32.15
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
32.15
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
12.49
|
13.66
|
32.74
|
--
|
Net Margin
21.28
Higher than Peers by 15.66
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
21.28
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.63
|
2.96
|
2.70
|
2.53
|
--
|
Cash Profit Margin
22.53
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
22.53
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
39.85
|
38.90
|
--
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
12.85
|
218.06
|
--
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
33.33
|
200.00
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.72
Higher than Peers by 0.50
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
0.72
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.22
|
0.20
|
0.19
|
0.38
|
--
|
Short term debt to equity ratio
0.38
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
0.38
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.03
Higher than Peers by 0.04
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
2.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.99
|
2.03
|
1.95
|
1.92
|
--
|
Quick Ratio
1.54
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
1.54
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
1.12
|
1.24
|
5.88
|
--
|
Interest Coverage
8.47
Higher than Peers by 4.32
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
8.47
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.14
|
2.98
|
3.48
|
2.73
|
--
|
Operating Efficiency
Debtors to sales
34.75
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
34.75
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
29.85
|
41.06
|
55.67
|
--
|
Asset Turnover
0.98
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
0.98
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
1.55
|
3.06
|
1.38
|
--
|
Receivable days
126.83
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
126.83
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
63.99
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
63.99
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
39.74
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
39.74
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
151.09
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
151.09
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
44.20
|
39.23
|
34.42
|
43.43
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.96
|
2.56
|
2.03
|
1.76
|
--
|
EV/EBITDA
1.56
Lower than Peers by 21.59
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
1.56
|
--
|
--
|
--
|
--
|
|
Peer Median
|
23.15
|
24.73
|
22.79
|
18.08
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Anondita Medicare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
55
|
58
|
40
|
20
|
--
|